enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Pembrolizumab - Wikipedia

    en.wikipedia.org/wiki/Pembrolizumab

    Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer. [12] [14] [15] [16] It is administered by slow intravenous ...

  3. Threshold dose - Wikipedia

    en.wikipedia.org/wiki/Threshold_dose

    Threshold dose is the minimum dose of drug that triggers minimal detectable biological effect in an animal. [1] At extremely low doses, biological responses are absent for some of the drugs. The increase in dose above threshold dose induces an increase in the percentage of biological responses. [ 2 ]

  4. Lenvatinib - Wikipedia

    en.wikipedia.org/wiki/Lenvatinib

    Lenvatinib, sold under the brand name Lenvima among others, is an anti-cancer medication for the treatment of certain kinds of thyroid cancer and for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1 , VEGFR2 and VEGFR3 kinases.

  5. Favezelimab/pembrolizumab - Wikipedia

    en.wikipedia.org/wiki/Favezelimab/pembrolizumab

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more

  6. Wikipedia:WikiProject Medicine/Lists of pages/Articles ...

    en.wikipedia.org/wiki/Wikipedia:WikiProject...

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us

  7. FOLFOX - Wikipedia

    en.wikipedia.org/wiki/FOLFOX

    The dose schedule given every two weeks is as follows: [5] Day 1–2: Oxaliplatin 100 mg/m 2 IV infusion, given as a 120 minutes IV infusion in 500 mL D5W, concurrent with leucovorin 400 mg/m 2 (or levoleucovorin 200 mg/m 2) IV infusion, followed by 5-FU 400 mg/m 2 IV bolus, followed by 46-hour 5-FU infusion (2400 mg/m 2 for first two cycles, and may be increased to 3000 mg/m 2 if tolerated by ...

  8. Imatinib - Wikipedia

    en.wikipedia.org/wiki/Imatinib

    Imatinib is rapidly absorbed when given by mouth, and is highly bioavailable: 98% of an oral dose reaches the bloodstream. Metabolism of imatinib occurs in the liver and is mediated by several isozymes of the cytochrome P450 system, including CYP3A4 and, to a lesser extent, CYP1A2 , CYP2D6 , CYP2C9 , and CYP2C19 .

  9. Polatuzumab vedotin - Wikipedia

    en.wikipedia.org/wiki/Polatuzumab_vedotin

    Polatuzumab vedotin, sold under the brand name Polivy, is a CD79b-directed antibody-drug conjugate medication used for the treatment of diffuse large B-cell lymphoma (). [6]